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Defense systems against infec-
tious agents can be subdivided into 
two broad categories involving 
humoral and cellular mechanisms. 
Specific humoral systems comprise 
the antimicrobial and antitoxic ef-
fects of at least three classes (lgG, 
lgM and lgA) of immunoglobu-
lins. These immunoglobulins in 
varying patterns may (a) neutral-
ize toxins, (b) neutralize viral in-
fectivity and ( c) kill certain gram-
negative microorganisms in con-
cert with the complement system. 
A few microorganisms having 
"deficient" cell walls, such as myco-
plasma, may be inhibited by specific 
antibodies without the aid of com-
plement. Since lgA does not fix 
complement, lgG and lgM must 
play the dominant role in comple-
ment mediated reactions. A fourth 
( d) category of specific immu-
noglobulin activity involves en-
hancement of phagocytosis or 
opsonic action, which illustrates an 
important interplay between a 
specific humoral mechanism and 
phagocytic mechanisms. It is prob-
able that lgG and lgM also play 
the dominant role in opsonization, 
because lgA has been reported to 
lack opsomzmg activity (Quie, 
Messner and Williams, 1968). The 
major functions of lgA must be to 
neutralize toxins and the infectivity 
of viruses. 
In addition to specific humoral 
mechanisms, several nonspecific hu-
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moral defense mechanisms exist. 
Two such factors are ,8-lysin, which 
is released during blood clot for-
mation (Tew, Hess and Donald-
son, 1969), and lysozyme, which is 
probably secreted and/or released 
from several cell types. It is signifi-
cant that lysozyme can act in con-
cert with the antibody-complement 
system and augment the bacteri-
cidal and lytic effects of this sys-
tem against certain gram-negative 
microorganisms (Amano et al., 
1954). Lysozyme is usually pres-
ent in lysosomes of phagocytic cells 
and may be secreted by mono-
nuclear cells (Heise and Myrvik, 
1967). Other potentially active 
nonspecific factors secreted from 
living cells or released from dis-
rupted and necrotic cells include 
cationic substances, lactate, inter-
feron, viral inhibitors and a re-
cently described antibacterial sys-
tem involving peroxidase, 
thiocyanate and H20• (Hirsch, 
1960; Klebanoff, Clem and Luebke, 
1966; Wolstenholme and O'Con-
nor, 1967; Zeya and Spitznagel, 
1968). 
If a microorganism is not in-
activated by the humoral mechan-
isms present in the microenviron-
ment at the site of infection, 
phagocytic cells promptly come 
into play, and, if conditions permit, 
the infecting microorganisms will 
be ingested. The polymorphonu-
clear (PMN) cell is usually the 
first line of phagocytic cells to en-
gage microorganisms. However, if 
the infection continues and is not 
contained by the PMNs, mono-
nuclear phagocytes (macrophages) 
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eventually engulf the parasite and, 
if necessary, can enter into a long-
term engagement with the infec-
tious agent. During this interaction 
both nonspecific and specific hu-
moral factors may participate prior 
to and perhaps even conjointly with 
the intracellular events. It is gen-
erally considered that the phago-
somes in PMNs and macrophages 
receive antibacterial factors and 
hydrolytic enzymes from lysosomes 
as the result of a fusion process 
between lysosomes and the mem-
brane surrounding the phago-
cytized particle (Hirsch, 1962). 
It would be expected that the 
least virulent of all microorgan-
isms might be highly susceptible 
to the nonspecific humoral systems 
of defense. Such microorganisms 
would be represented by Sarcina 
lutea (sensitive to lysozyme) and 
Bacillus subtilis (sensitive to /3-
lysin). The next hierarchy of path-
ogenic microorganisms to evolve 
would be expected to be resistant 
to the humoral mechanisms and 
capable of resisting phagocytosis 
unless specific opsonizing antibody 
is present. Diplococcus pneumo-
niae is a representative of this type 
of host-parasite relationship. How-
ever, D. pneumoniae is fully sus-
ceptible to the normal intracellular 
bactericidal mechanisms once the 
organism has been ingested. In this 
case there is no evidence that 
specific opsonizing antibody con-
tributes significantly to the normal 
intracellular bactericidal and di-
gestive activities of PMNs and 
macrophages except for mediating 
phagocytosis. 
The ultimate evolutionary step 
reached by microorganisms has in-
volved not only resistance to the 
humoral systems of defense, but 
also resistance to the normal base-
line cellular systems of defense. 
Mycobacterium tuberculosis is a 
classic example of a parasite reach-
ing this stage of host-parasite evo-
lution. In fact, all of our so-called 
chronic granulomatous diseases 
(tuberculosis, brucellosis, listeri-
osis, histoplasmosis, tularemia, 
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etc.) are chronic and granuloma-
tous because of a persisting intra-
cellular infection of the phagocytic 
cells of the reticuloendothelial sys-
tem. Characteristically the infec-
tious lesion in these host-parasite 
relationships is composed primarily 
of macrophages, epithelioid cells, 
giant cells and lymphoid cells. 
Macrophages in a "status quo" 
nonimmunized animal are essen-
tially incapable of resisting the in-
tracellular growth of virulent tu-
bercle bacilli. Furthermore, the 
PMNs fail, in all probability, be-
cause their life span is too short 
to effectively bring to bear their 
bactericidal and digestive systems 
against an organism with such 
challenging substrates and bio-
chemical armor as the virulent 
tubercle bacillus. Accordingly, the 
ultimate in parasite evolution has 
resulted in microorganisms with 
complex cell walls and "capsular" 
substrates that are refractory to 
the normal bactericidal and/ or 
digestive processes of the phago-
cytic cell systems. An alternative 
to this possibility could involve 
toxic moieties secreted or released 
intracellularly by a pathogenic 
microorganism which could disrupt 
the chain of events leading to an 
effective phagosome or block dif-
ferentiation to an increased im-
munologic potential. 
In this regard, PMNs are quite 
capable of digesting Mycobacter-
ium smegmatis within three hours, 
which illustrates their potential for 
killing an avirulent species of 
mycobacteria (Leake and Myrvik, 
1966). Consequently, virulent 
mycobacteria are biochemically 
structured in a way which allows 
them to survive the intracellular 
potential of the PMN and makes 
them candidates ultimately for 
phagocytosis by macrophages. Nor-
mal macrophages appear to under-
go a form of non-immunologic 
mediated differentiation and can 
kill M. smegmatis after about 
four to six days of intracellular 
residence. However, macrophages 
can cope only with virulent myco-
bacteria after they have differenti-
ated in vivo under the blanket of an 
immunologic stimulus. Accordingly, 
there is good evidence to support 
the concept that normal macro-
phages are relatively immature 
cells and can differentiate upon 
demand by either stimulation with 
"substrate" or some specific im-
munological mechanism (Evans 
and Myrvik, 1968) . In addition, 
these forms of stimulation may 
lead to mitosis, resulting in a more 
favorable host cell-parasite ratio. 
Undoubtedly, macrophages acti-
vated by a specific immunologic 
mechanism develop a population 
of "immune" phagocytes sooner 
than by way of the "substrate" 
principle of stimulation. For ex-
ample, sodium stearate will de-
velop a characteristic epithelioid 
cell granuloma which has the same 
rate of formation regardless of the 
number of injections. In contrast, 
repeated injections of mycobacteria 
illustrate the development of so-
called accelerated or allergic gran-
u lo mas (Myrvik, Leake and 
Oshima, 1962) . 
The PMN normally emerges 
from the bone marrow as a mature 
cell with a constitutive load of 
antibacterial and digestive factors 
packaged in lysosomes. It thus ap-
pears that opsonizing antibody is 
the main specific immunologic 
component that interplays directly 
with the PMN. It is also feasible 
in certain instances for bactericidal 
antibody plus complement to inter-
play with lysozyme and, possibly, 
other antibacterial agents that are 
transferred to the phagosome. In 
addition, certain components of 
complement have been demon-
strated to exert positive chemotactic 
effects on PMNs (Mi.iller-Eberhard, 
1968). However, chemotaxis of 
PMNs also can be prompted by 
components resulting from tissue 
damage apart from specific antigen-
antibody-complement reactions or 
other specific sensitivity responses. 
~There is no evidence that PMNs 
proliferate in tissues as a result of 
a specific immunologic stimulus. 
Therefore, mobilization to any le-
sion is dependent on blood-borne 
transport. 
In contrast, macrophages com-
monly circulate or exist in tissues 
as relatively undifferentiated cells 
with a sparse number of lysosomes 
and a low level of hydrolases as 
well as a baseline level of metabolic 
activity (Heise, Myrvik and Leake, 
1965; Myrvik and Evans, 1967; 
Leake and Myrvik, 1968). It is 
of interest that normal alveolar 
macrophages, even of a low order 
of activation, can readily kill and 
digest avirulent strains of Listeria 
monocytogenes but not virulent 
strains of this organism (Evans, 
1968). However, BCG-(Mycobac-
terium bovis) activated alveolar 
macrophages are capable of killing 
virulent strains of L. monocyto-
genes. These findings indicate that, 
once a macrophage is activated by 
interaction with one type of micro-
organism, it also has an increased 
potential to contain and destroy 
certain unrelated microorganisms. 
It should be emphasized that this 
generalization does not hold when 
BCG-activated macrophages are 
presented with virulent Pasteurella 
tularensis. On the other hand, 
macrophages from P. tularensis-
vaccinated animals are capable of 
handling P. tularensis (Nutter and 
Myrvik, 1966). 
Whereas the role of specific 
antibodies and their interplay with 
PMNs is reasonably well under-
stood, our concepts concerning the 
interplay of specific antibodies and 
acquired immunity to facultative 
intracellular parasites (the ultimate 
in evolution of microbial patho-
gens) is obscure. Speculation is 
our only modus operandi for dis-
cussing this facet of cellular im-
munity. There is compelling evi-
dence that with most facultative 
intracellular parasites opsonizing 
antibody is not the limiting fac-
tor. For example, there appears 
to be an adequate concentration 
of opsonins in normal sera for my-
cobacteria and listeria. These op-
sonins could be the result of long-
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term contact with similar or related 
organisms in the environment. Ac-
cordingly, opsonins (if needed with 
these organisms) are usually nor-
mally present, and, thus, phagocytic 
uptake by macrophages is not the 
limiting step following primary in-
fection with these organisms. This 
does not exclude the possibility that 
phagocytosis of some facultative in-
tracellular parasites may be depend-
ent on antibodies present only in 
the specifically immune host. Never-
theless, the key point in our un-
derstanding of the host-parasite 
relationship in the so-called granu-
lomatous diseases rests on the fact 
that normal macrophages are 
incapable of suppressing the in-
tracellular parasite even if sufficient 
time is allowed for "substrate" 
activation. This is exemplified in 
the case of tuberculosis, where the 
generation time of the parasite is 
probably two to four days in vivo. 
In this host-parasite relationship, it 
is quite apparent that only immune 
macrophages can significantly sup-
press the growth of tubercle 
bacilli. 
Assuming that the macrophages 
which mediate immunity to tuber-
culosis are derived as the result of 
some specific immunologic activa-
tion process, an interplay of spe-
cific and nonspecific factors in 
cellular immunity must be postu-
lated. 
Current knowledge in this area 
supports the concept that immune 
lymphocytes are activated follow-
ing contact with the corresponding 
antigen. As a result, these lympho-
cytes undergo transformation and 
secrete either specific antibody with 
cytophilic properties for macro-
phages or a product (Granger's 
lymphotoxin?) which can activate 
macrophages (Granger and Kolb, 
1968; Heise, Han and Weiser, 
1968). If cytophilic antibody is in-
volved, the macrophages passively 
receive a recognition system ( cyto-
philic antibody) which could func-
tion to specifically activate macro-
phages when they have made con-
tact with the appropriate antigen. 
On the other hand, if a nonspecific 
secretion product of the specifically 
activated immune lymphoid cells is 
responsible, specificity of the re-
sponse would not exist on the 
macrophage level. However, it is 
unlikely that the effector cell 
(macrophage) of antibacterial cel-
lular immunity is totally devoid of 
specific components. Cytophilic 
antibodies on macrophages could 
function in an "antitoxic" capacity 
on the intracellular level.. This 
possibility is best exemplified by 
the lack of immune expression of 
BCG-activated (immune) macro-
phages against P. tularensis. In con-
trast, macrophages derived from P. 
tularensis-immune animals express 
definite cellular immunity against 
P. tularensis. The possibility that 
certain types of antibody could 
function on the intracellular level 
to protect the macrophage against 
toxic products secreted by intracel-
lular pathogens warrants investiga-
tion. 
In transplantation immunity it 
appears likely that immune lymph-
oid cells act directly as effector 
cells. In this case, macrophages 
may act only as a secondary partic-
ipant, which is in contrast to the 
primary role macrophages play in 
antibacterial cellular immunity. 
The case for a lymphotoxin being 
an effector agent in transplantation 
immunity is attractive and deserves 
further study. 
Summary 
The total complex of immune 
expression is an interplay between 
nonspecific antimicrobial humoral 
systems plus specific antibodies and 
accessory factors. These systems 
are backstopped by the phagocytic 
functions of PMNs. If these fail, 
mononuclear phagocytes respond 
as a second line of defense to 
carry out chronic engagements. In 
addition to a direct activation pro-
cess by "substrate," macrophages 
may be activated and mobilized by 
a lymphocyte-mediated immuno-
logic reaction which probably in-
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volves either a "lymphotoxin" and/ 
or a specific antibody cytophilic for 
macrophages. Immunologically ac-
tivated lymphocytes appear to be 
the primary effector cells of anti-
tissue (transplantation) cellular im-
munity, whereas immunologically 
activated macrophages appear to be 
the primary effector cells of anti-
bacterial cellular immunity. 
References 
AMANO, T., S. INAI, Y. SEKI, s. KASH-
IBA, K. FUJIKAWA AND S. NISHI-
MURA. Studies on the immune 
bacteriolysis. I. Accelerating effect 
on the immune bacteriolysis by 
lysozyme-like substance of leuco-
cytes and egg-white lysozyme. Med. 
J. Osaka Univ. 4:401-418, 1954. 
EVANS, D. G. Glucose metabolism of 
normal and immune alveolar mac-
rophages, thesis, Bowman Gray 
School of Medicine, Wake Forest 
University, Winston-Salem, North 
Carolina, 1968. 
EVANS, D. G. AND Q. N. MYRVIK. 
Studies on glucose oxidation during 
the interaction of alveolar macro-
phages and bacteria. Ann. N.Y. 
A cad. Sci. 154:167-176, 1968. 
GRANGER, G. A. AND w. P. KOLB. 
Lymphocyte in vitro cytotoxicity: 
Mechanisms of immune and non-
immune small lymphocyte mediated 
target L cell destruction. J. lm-
munol. 101: 111-120, 1968. 
HEISE, E. R., S. HAN AND R. S. 
WEISER. In vitro studies on the 
mechanism of macrophage migra-
tion inhibition in tuberculin sensi-
tivity. J. lmmunol. 101: 1004-1015, 
1968. 
HEISE, E. R. AND Q. N. MYRVIK. 
Secretion of lysozyme by rabbit 
alveolar macrophages in vitro. J. 
Reticuloendothel. Soc. 4:510-523, 
1967. 
HEISE, E. R., Q. N. MYRVIK AND E. s. 
52 
LEAKE. Effect of Bacillus Calmette-
Guerin on the levels of acid phos-
phatase, lysozyme and cathepsin 
in rabbit alveolar macrophages. J. 
lmmunol. 95: 125-130, 1965. 
HIRSCH, J. G. Antimicrobial factors 
in tissues and phagocytic cells. 
Bacterial. Rev. 24: 133-140, 1960. 
---. Cinemicrophotographic ob-
servations on granule lysis in poly-
morphonuclear leucocytes during 
phagocytosis. J. Exp. Med. 116: 
827-834, 1962. 
KLEBANOFF, S. J., W. H. CLEM AND 
R. G. LUEBKE. The peroxidase-
thiocyanate-hydrogen peroxide anti-
microbial system. Biochim. Biophys. 
Acta 117: 63-72, 1966. 
LEAKE, E. S. AND Q. N. MYRVIK. Di-
gestive vacuole formation in 
alveolar macrophages after phago-
cytosis of Mycobacterium smeg-
matis in vivo. J. Reticuloendothel. 
Soc. 3:83-100, 1966. 
---. Changes in morphology and 
in lysozyme content of free alveolar 
cells after the intravenous injection 
of killed BCG in oil. J. Reticuloen-
dothel. Soc. 5: 33-53, 1968. 
MULLER-EBERHARD, H. J. Chemistry 
and reaction mechanisms of com-
plement. Advan. Immunol. 8: 1, 
1968. 
MYRVIK, Q. N. AND D. G. EVANS. 
Effect of Bacillus Calmette Guerin 
on the metabolism of alveolar 
macrophages. Advan. Exp. Med. 
Biol. 1 :203-213, 1967. 
MYRVIK, Q. N., E. S. LEAKE AND S. 
OSHIMA. A study of macrophages 
and epithelioid-like cells from gran-
ulomatous (BCG-induced) lungs of 
rabbits. J. Immunol. 89:745-751, 
1962. 
NUTTER, J. E. AND Q. N. MYRVIK. In 
vitro interactions between rabbit 
alveolar macrophages and Pasteur-
ella tularensis. J. Bacterial. 92: 645-
651, 1966. 
QUIE, P. G., R. P. MESSNER AND R. c. 
WILLIAMS, JR. Phagocytosis in sub-
acute bacterial endocarditis. Local-
ization of the primary opsonic site 
to Fe fragment. J. Exp. Med. 128: 
553-570, 1968. 
TEW, J. G., w. M. HESS AND D. M. 
DONALDSON. Lysozyme and ,8-lysin 
release stimulated by antigen-
antibody complexes and bacteria. 
J. lmmunol. 102:743-750, 1969. 
WOLSTENHOLME, G. E. W. AND M. 
O'CONNOR (eds.). CIBA Founda-
tion Symposium on Interferon. Bos-
ton: Little, Brown, 1967. 
ZEYA, H. I. AND J. K. SPITZNAGEL. 
Arginine-rich proteins of polymor-
phonuclear leucocyte lysosomes: 
Antimicrobial specificity and bio-
chemical heterogeneity. J. Exp. 
Med. 127:927-941, 1968. 
